Newsletter Signup | Join Community
Tecentriq® Improves NSCLC survival when combined with Avastin & chemotherapy Regardless of PD-L1 Status.
Mesothelin-targete CAR T-cell therapy has shown early evidence of effectiveness in patients with NSCLC.
FLAURA study confirms Tagrisso as best initial treatment of EGFR + NSCLC - learn more about its role in NSCLC management
Lung Cancer; Risk factors, diagnostic evaluation, staging and treatment planning.
RELAY & REVEL Demonstrate role of Cyramza in management of EGFR mutated advanced NSCLC.
Tagrissio, Tarceva and other TKI therapy for EGFR + NSCLC continue to evolve and improve survival.
Surgery, radiation, and systemic chemotherapy - precision cancer medicines are all used to treat stage IIIA NSCLC
Tarceva™ Improves Survival in Non-Small Cell Lung Cancer
I have small cell lung cancer; radiation to prevent spread to the brain has been recommended but…
HER 2 + Lung Cancer Treatment? https://coloradocancerblogs…
Dana Farber and MDACC discover why anti-PD 1 immunotherapy doesnt work in some patients and work to…
High incidence of ROS 1 false negative tests reported by U Colorado researchers. http://www…